Antivirals TRIZ Cases

Antibody-drug conjugates link antiviral payloads to binding agents, achieving broad neutralization across multiple influenza A subtypes.

Non-palindromic sequences in recombinant vectors create functional RNA libraries, resolving the trade-off between synthesis ease and biological suitability.

A pharmaceutical composition of entecavir monohydrate uses sodium starch glycolate and sodium stearyl fumarate to ensure content uniformity.

PEGtide dendrons combine peptide and polyethylene glycol subunits to create carriers with high drug loading capacity.

Composite oleander extracts inhibit viral replication and reduce infectivity while minimizing toxicity via synergistic multi-component activity.

Intermittent histone deacetylase inhibitor dosing schedules manage side effects in cancer treatment.

Combining mecamylamine with pioglitazone blocks viral entry and reduces inflammatory cytokine expression.

Segmenting dilution, separation, and recrystallization stages recovers high-purity cellulose II while maintaining manageable process complexity.

One or two doses of emtricitabine, tenofovir alafenamide, elvitegravir, and cobicistat prevent HIV infection without prolonged daily dosing.

Transfusing immune activated allogeneic serum bypasses complex in vitro reprogramming to induce M1 macrophage polarization.

6-deoxyglucose-diphyllin inhibits viral entry by blocking endosomal acidification.

An ADAMTS4 inhibitor combined with an antibiotic reduces immunopathology and secondary bacterial infections in severe respiratory disease treatment.

C-17 bicyclic amines derived from betulinic acid constrain capsid protein assembly to produce non-infectious viruses and overcome drug resistance.

Lactam derivatives inhibit coronavirus 3C-like protease, reducing viral load and treating severe respiratory infections.

A dispersible tablet formulation containing dolutegravir, abacavir, and lamivudine with taste masking agents.

Abacavir targets TDP1-deficient cancer cells to induce lethal DNA breaks while sparing normal cell replication.

Amorphous maraviroc formulations with controlled particle size overcome suboptimal dissolution characteristics to enhance bioavailability.

Berbamine prevents flavivirus entry into host cells, addressing ineffective RNA virus treatments.

Subcritical carbon dioxide extraction removes hepatotoxic pyrrolizidine alkaloids from Petasites, enabling safe treatment of viral infections.

A fixed-dose herbal composition combines Lagerstroemia speciosa, Euphorbia hirta, and Zingiber officinale extracts to treat dengue.

A traditional Chinese medicine composition merges five specific herbal ingredients to enhance immune function and increase leukocyte counts.

Specific cellular markers detect latent viral reservoirs, enabling targeted eradication strategies that prevent viral rebound upon treatment cessation.

Plant extracts from Achillea and Cornus species directly inhibit HSV-1 viral replication, addressing limitations of conventional synthetic antiviral treatments.

Ab-CD4 conjugates link antibodies to CD4 compounds, neutralizing HIV virions while eliminating infected cells through Fc-mediated effector functions.

A composite herbal extract containing agarwood and honeylocust targets viral entry mechanisms.

Lactobacillus and Bifidobacterium strains block viral spike protein attachment to host cell receptors.

Peptide sequences targeting matrix proteins inhibit enveloped viruses while avoiding toxicity and resistance issues common in small molecule drugs.

Adenosine A2A receptor agonists reduce pro-inflammatory cytokines and mortality by inhibiting iNKT cell activation in cytokine storm syndrome.

Methanolic Cissampelos pareira extracts reduce dengue virus titers through targeted antiviral activity.

Homoharringtonine reduces cytotoxicity while blocking SARS-CoV-2 replication by exploiting length differences in open reading frames.

Segmenting a multilayer tablet isolates tenofovir DF from surfactant-containing efavirenz, preventing rapid degradation and ensuring bioequivalence.

Fluoropolymer stopper coatings reduce antigen desorption by blocking competing adsorption sites on standard container materials.

Bioerodible films deliver antiviral agents through controlled polymer erosion, resolving user adherence and leakage issues.

Ethanol extraction standardizes a multi-herb formulation to inhibit viral replication without cytotoxicity.

Fusing heterologous polypeptides to glycoprotein H redirects herpesvirus infection toward cancer cells, resolving the trade-off between safety and replication.

Androgen receptor blockers reduce all-cause mortality by 77.7% in sepsis patients through viral clearance acceleration.

Modifying triazine-2,4-dione substituents achieves potent 3CLpro inhibition while reducing cytotoxicity against mutant strains.

A tumor cell co-expresses a target antigen and CD1d to activate NKT cells and cytotoxic T lymphocytes simultaneously.

TLR7 agonists trigger transient viremia to expose dormant HIV reservoirs, enabling antiretroviral therapies to eliminate infected cells.

Sortase enzymes attach drugs to natural red blood cells via stable amide bonds, avoiding genetic engineering complexity and improving agent retention time.

Merging RdRp and NS5A inhibitors overcomes limited treatment options by terminating viral RNA replication.

Compounds binding the Tat-TAR complex promote transcriptional activity to reactivate latent HIV-infected cells without inhibiting CD8 cell cytotoxic function.

Succinic acid derivatives treat haematological disorders by inducing thrombocyte differentiation, addressing underutilized pharmaceutical applications.

A topical kit combines Croton lechleri resin extract with Melaleuca alternifolia oil to accelerate cutaneous ulcer healing.

Melissa officinalis extracts bind viral glycoprotein B, blocking filovirus attachment and replication with low cytotoxicity.

Ultrafiltration membranes with 400-1000 Da cut-offs enrich anthocyanins and polysaccharides to preserve nutrients lost in conventional extraction.

Acid sphingomyelinase inhibitors reduce blood and cell ceramide levels, blocking SARS-CoV-2 entry and lowering intubation risk.

Converting SCY-635 to a maleate salt resolves poor bioavailability, enabling effective hepatitis C treatment.

Topical polyethylene glycol reduces herpes labialis relapse frequency through hygroscopic virus replication inhibition.

Combining vardenafil with Remdesivir creates synergistic antiviral effects that address inadequate single-agent treatment efficacy.